Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
Bertagnolio S, Hermans L, Jordan MR, Avila-Rios S, Iwuji C, Derache A, Delaporte E, Wensing A, Aves T, Borhan ASM, Leenus A, Parkin N, Doherty M, Inzaule S, Mbuagbaw L. Bertagnolio S, et al. Among authors: iwuji c. J Infect Dis. 2021 Aug 2;224(3):377-388. doi: 10.1093/infdis/jiaa683. J Infect Dis. 2021. PMID: 33202025 Free PMC article. Review.
HIV treatment as prevention: applicable in sub-Saharan Africa?
Newell ML, Iwuji C. Newell ML, et al. Among authors: iwuji c. Lancet Infect Dis. 2016 Jul;16(7):754-755. doi: 10.1016/S1473-3099(16)30057-3. Epub 2016 May 9. Lancet Infect Dis. 2016. PMID: 27174505 No abstract available.
Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
Collier D, Iwuji C, Derache A, de Oliveira T, Okesola N, Calmy A, Dabis F, Pillay D, Gupta RK; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 12249 Treatment as Prevention (TasP) Study Group. Collier D, et al. Among authors: iwuji c. Clin Infect Dis. 2017 Apr 15;64(8):1006-1016. doi: 10.1093/cid/cix015. Clin Infect Dis. 2017. PMID: 28329393 Free PMC article.
Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART.
Derache A, Iwuji CC, Danaviah S, Giandhari J, Marcelin AG, Calvez V, de Oliveira T, Dabis F, Pillay D, Gupta RK. Derache A, et al. Among authors: iwuji cc. J Antimicrob Chemother. 2019 Feb 1;74(2):473-479. doi: 10.1093/jac/dky428. J Antimicrob Chemother. 2019. PMID: 30380053 Free PMC article. Clinical Trial.
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
Havlir D, Lockman S, Ayles H, Larmarange J, Chamie G, Gaolathe T, Iwuji C, Fidler S, Kamya M, Floyd S, Moore J, Hayes R, Petersen M, Dabis F; (Universal Test, Treat Trials) UT3 Consortium. Havlir D, et al. Among authors: iwuji c. J Int AIDS Soc. 2020 Feb;23(2):e25455. doi: 10.1002/jia2.25455. J Int AIDS Soc. 2020. PMID: 32091179 Free PMC article.
77 results